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A unified protocol is essential to ensure that fetal ultrasound
measurements taken in multicentre research studies are accurate
and reproducible. This paper describes the methodology used to
take two-dimensional, ultrasound measurements in the
longitudinal, fetal growth component of the INTERGROWTH-21st
Project. These standardised methods should minimise the
systematic errors associated with pooling data from different study
sites. They represent a model for carrying out similar research
studies in the future.
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Introduction
The International Fetal and Newborn Growth Consortium
for the 21st Century (INTERGROWTH-21st) is a large-
scale, population-based, multicentre project involving
health institutions from eight geographically diverse coun-
tries, which aims to assess fetal, newborn and preterm
growth under optimal conditions, in a manner similar to
that adopted by the World Health Organization (WHO)
Multicentre Growth Reference Study (MGRS).1 The
INTERGROWTH-21st Project has three major components,
which were designed to create: (1) longitudinally derived,
prescriptive, international, fetal growth standards using
both clinical and ultrasound measures; (2) preterm, postna-
tal growth standards for those infants born at ≥26+0 but
<37+0 weeks of gestation in the longitudinal cohort; and
(3) birthweight-for-gestational-age standards derived from
all newborns delivering at the study sites over an approxi-
mately 12 month period.2
To ensure that ultrasound measurements in the longitu-
dinal component of the INTERGROWTH-21st Project—the
Fetal Growth Longitudinal Study (FGLS)—are accurate and
reproducible, it was essential that participating centres
adopted uniform methods because it is well recognised that
there are differences in practice between countries and
ultrasonographers. For example, different protocols exist
describing how to take fetal measurements, including where
to place callipers, and ultrasound equipment may not be
calibrated correctly.3
To achieve uniformity in FGLS, we used identical ultra-
sound equipment in all the study sites; developed standar-
dised methodology to take fetal measurements, and
employed locally accredited ultrasonographers who under-
went standardisation training and monitoring. This paper
describes the methodology used to take fetal measurements
in FGLS.
Overview of the ultrasound
procedures
The following ultrasound procedures are performed: (1)
crown–rump length (CRL) measurement to confirm the
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gestational age at 9+0 to 13+6 weeks of gestation; (2) serial
measurement of biparietal diameter (BPD), occipito-
frontal diameter (OFD), head circumference (HC), trans-
verse abdominal diameter (TAD), anterior-posterior
abdominal diameter (APAD), abdominal circumference
(AC) and femur length (FL) to describe fetal growth; (3)
serial assessment and measurement of amniotic fluid vol-
ume; and (4) documentation of placental localisation and
fetal presentation. The INTERGROWTH-21st Steering
Committee agreed the study methodology and definitions,
which were derived from published studies and consensus
documents.3–9 The fetal measurements were selected
because they form part of standard clinical care and they
have been evaluated in a number of large randomised
controlled trials.10
The ultrasound schedule
All mothers have a transabdominal ultrasound scan at 9+0
to 13+6 weeks from the first day of the last menstrual per-
iod to: (1) confirm the presence of a viable, singleton,
intrauterine pregnancy and (2) use the CRL measurement
to confirm the gestational age based on the last menstrual
period.11,12 Details of the methodology for CRL measure-
ment are presented elsewhere.13 Following this initial dating
scan, participants in FGLS have up to six fetal growth scans
at intervals of 5  1 weeks from 14+0 weeks of gestation
onwards until delivery, but not beyond 42+0 weeks of ges-
tation.
All scans from 14+0 weeks of gestation onwards are per-
formed using the same commercially available ultrasound
machine (Philips HD-9, Philips Ultrasound, Bothell, WA,
USA) with curvilinear abdominal transducers (C5-2, C6-3,
V7-3). The decision to use this machine was based on sev-
eral factors including the cost; feasibility of future use in
developing countries; acceptance by doctors and women;
manufacturer’s ability to provide technical support and will-
ingness to make the software changes needed to allow blind-
ing of measurements (i.e. values do not appear on screen, so
as to avoid potential bias associated with ‘expected’ values);
advice of experts in the field, and technical recommenda-
tions from the Royal College of Radiologists.14
We conducted site visits to a number of manufacturers
and explored a range of equipment from portable machines
to very sophisticated equipment with market prices ranging
from US$40,000 to US$150,000. We even considered using
second-hand equipment that could be adapted to our
needs. We identified three major technical requirements:
image clarity, resolution and the ability to differentiate tis-
sue structures (see full list of requirements in Supporting
Information, Appendix S1). It was decided to use new
equipment because there is some evidence that the narrow
ultrasound beam width in more modern machines is asso-
ciated with lateral measurements that are more representa-
tive of true length.15 Candidate machines were then tested
against these criteria bearing in mind the need to ensure
that the machine eventually chosen should be affordable in
the future in developing countries.
2-dimensional ultrasound measurements
Using three separate images, three blinded measurements
are taken of each fetal biometric variable: BPD, OFD,
APAD, TAD, FL, HC and AC, with the woman in the lat-
eral recumbent position. In addition, the Amniotic Fluid
Index, to assess amniotic fluid volume, and the fetal pre-
sentation and placental position are documented. All
images are stored on the machine’s hard drive.
The three head measurements (BPD, OFD, and HC
using the ellipse facility) are all taken in the same view
(Figure 1). To achieve this, a cross-sectional view of the
fetal head at the level of the thalami is taken as close as
possible to the horizontal (angle of insonation as close as
possible to 90°). The head should be oval in shape, sym-
metrical, centrally positioned and filling at least 30% of the
monitor. The midline echo (representing the falx cerebri)
should be broken anteriorly, at one-third of its length, by
the cavum septi pellucidi. The thalami should be located
symmetrically on either side of the midline. For the BPD
measurement, the intersection of the callipers should be
placed on the outer border of the parietal bones (‘outer to
outer’) at the widest part of the skull. For the OFD mea-
surement, the intersection of the callipers should be placed
on the outer border of the occipital and frontal bones
(‘outer to outer’) at the longest part of the skull. At this
point, the image (with the callipers visible) is saved. Fol-
lowing this, the callipers are removed and, on the same still
view, the HC is measured using the ellipse facility. The line
of the ellipse should be placed on the outer border of the
skull. The measurements of BPD, OFD and HC are
repeated twice more on two, newly acquired views. The
HC is also calculated from the BPD and OFD measure-
ments using the formula HC = p(BPD + OFD)/2.
The three measurements of the abdomen (APAD, TAD
and AC using the ellipse facility) are all taken in the same
view (Figure 2). To achieve this, a cross-sectional view of
the fetal abdomen is taken as close as possible to circular,
with the umbilical vein in the anterior third of the abdo-
men (at the level of the portal sinus), with the stomach
bubble visible. The abdomen should fill at least 30% of the
monitor. The spine should preferably be positioned at
either 3 or 9 o’clock to avoid internal shadowing. The kid-
neys and bladder should not be visible. The ultrasonogra-
pher should avoid applying too much pressure with the
transducer, which can distort the circular shape of the fetal
abdomen. For the measurements, the intersection of the
callipers is placed on the outer borders of the body outline
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Figure 1. The level of the cross-section through the fetal head for correct measurement (A). The image (B) is well magnified, the head is horizontal,
oval in shape and symmetrical. The landmarks are seen with a centrally positioned and continuous midline falx cerebri (1), the midline echo is broken
anteriorly at one-third of its length by the cavum septi pellucidi (2) and the thalami are located symmetrically (3). Callipers are placed so that their
intersection is on the outer border of the bones (C). When using the ellipse facility this should run along the outer border of the skull (D).
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Figure 2. The level of the cross-section through the fetal abdomen for correct measurement (A). The image (B) is well magnified and the section is
circular. The landmarks are seen with a short segment of umbilical vein in the anterior third (at the level of the portal sinus) (1), the stomach bubble
is visible (2) and the spine (3) is lateral. Neither the bladder nor the kidneys should be visible. Callipers are placed so that their intersection is on the
outer border of the body outline (skin covering) (C). When using the ellipse facility this should run along the outer border of the abdomen (D).
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(skin covering). For the APAD, the intersection of the
callipers should be placed from the posterior aspect (skin
covering the spine) to the anterior abdominal wall. For the
TAD measurement, the intersection of the callipers should
be placed at 90° to the APAD across the abdomen at the
widest point. Following this, the callipers are removed and,
on the same still view, the AC is measured using the ellipse
facility. The line of the ellipse should be placed on the outer
border of the abdomen. The measurements of TAD, APAD
and AC are repeated twice more on two newly acquired
views. The AC is also calculated from the APAD and TAD
measurements using the formula AC = p(APAD + TAD)/2.
The FL is the only measurement taken of the femur
(Figure 3). To achieve this, a longitudinal view of the fetal
thigh closest to the probe is taken with the femur as close
as possible to the horizontal plane. The angle of insonation
of the ultrasound beam is 90° with the full length of the
bone visualised, unobscured by shadowing from adjacent
bony parts. The femur should fill at least 30% of the moni-
tor. The intersection of the callipers is placed on the outer
borders of the edges of the femoral diaphysis (outer to
outer) ensuring that the trochanter is not included in the
measurement. This is repeated twice more on two newly
acquired views.
At the end of the two-dimensional examination, ultraso-
nographers rate the quality of their images based on an
image-scoring algorithm16 (Table 1). Using this system, an
image in the correct plane scores, for example, a maximum
of 6 points for the head and abdomen. Images that do not
score the maximum points are repeated until the best pos-
sible score is achieved.
Assessment of amniotic fluid
Amniotic fluid volume can be classified into broad cate-
gories; this appears to be a reliable measure in experi-
enced hands, but is difficult to standardise. In this study,
the ultrasonographers are first asked to record the amni-
otic fluid volume subjectively as: polyhydramnios,
increased, normal, reduced, oligohydramnios, or anhy-
dramnios. Following this, the Amniotic Fluid Index is
measured objectively once (Figure 4). To achieve this, the
uterus is divided into quadrants using the umbilicus as a
reference (at <20+0 weeks of gestation the uterus is
divided into quadrants using the midpoint of the uterus).
The probe is held longitudinally to the mother and at 90°
to the floor. The deepest vertical pool in each quadrant
that contains no fetal parts or umbilical cord is measured
sequentially.
Presentation and placental localisation assessment
Fetal presentation and placental localisation are docu-
mented as they may affect fetal measurements. Fetal pre-
sentation is recorded in relation to the longitudinal axis of
the mother as cephalic, breech, transverse or oblique. Pla-
cental position is recorded as fundal, high anterior, high
posterior, high right lateral, high left lateral, low anterior,
low posterior, low right lateral, or low left lateral.
Special clinical situations
Sometimes, the standard operating procedures described
above cannot be followed. The most likely circumstances
were anticipated and a protocol was prepared indicating
the corrective action to take.
Difficulty in obtaining optimal measurements
Every effort is made to obtain the best possible measure-
ments based on the guidelines above. However, the fetal
position may on occasion be persistently unfavourable. In
such cases, we ask the woman to return within 1 week for
the scan to be repeated. If it remains impossible to obtain
good quality measurements, then the best possible set of
images is taken. The INTERGROWTH-21st Ultrasound
Coordinating Unit will be made aware because the image
score will be suboptimal in such cases.
Missing a scan appointment
If a woman misses an appointment, we always try to re-
schedule another within 1 week. If this is not possible, the
A
B
Figure 3. The level of the section through the fetal femur for correct
measurement (A and B). Only the ossified diaphysis (1) of the femur
should be measured. The greater trochanter (2) and distal ossification
centre (3) should be avoided in measuring the femur length as this
results in an excessive measurement.
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next scheduled appointment in the 5-week cycle is kept
and the missed appointment is not rescheduled.
Morphological abnormalities detected during an
examination
A morphological evaluation is conducted in every centre
at approximately 20 weeks of gestation. Any fetal abnor-
mality diagnosed is then managed according to local clin-
ical guidelines. If the woman continues with the
pregnancy, she remains in the study until delivery; how-
ever, a full evaluation of the abnormality is conducted in
the neonate and a specific data collection form is
completed. Cases with predefined minor abnormalities
that do not impact on fetal growth will be included in
the data analyses at the end of the study, but all others
will not.
Multiple pregnancy
In the unlikely event that a previously undiagnosed multi-
ple pregnancy is detected at the time of a growth scan, the
woman is advised that she cannot remain in the study.
Appropriate clinical care is then arranged.
Discussion
In this paper, we have described the methodology used in
the FGLS component of the INTERGROWTH-21st Project
to acquire ultrasound-based, fetal biometric measurements.
It should be read in conjunction with the corresponding
papers on standardisation of CRL measurement13 and
ultrasound quality control17 that also appear in this supple-
ment. The methodology described represents a model for
capturing, in a standardised manner for research purposes,
fetal biometric data obtained by multiple ultrasonographers
across different study sites.
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Figure 4. Amniotic Fluid Index (AFI) measurement. The uterus is divided into quadrants using the umbilicus as a reference (A). The probe is held
longitudinally to the mother and at 90° to the floor. The deepest vertical pool in each quadrant (B) that contains no fetal parts or umbilical cord is
measured sequentially.
Table 1. Image scoring criteria used for the standardisation exercise, based on Salomon et al.16
Cephalic plane (max. 6 points) Abdominal plane (max. 6 points) Femoral plane (max. 4 points)
1 Symmetrical plane 1 Symmetrical plane 1 Both ends of the bone clearly visible
2 Thalami visible 2 Stomach bubble visible 2 Angle <45°
3 Cavum septi pellucidi visible 3 Umbilical vein one-third of the way along the
abdominal plane (portal sinus)
3 Femur occupying at least 30% of image
4 Cerebellum not visible
4 Kidneys not visible
4 Callipers placed correctly
5 Head occupying at least 30% of image
5 Abdomen occupying at least 30% of image6 Callipers / ellipse placed correctly
6 Callipers / ellipse placed correctly
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authors. The protocol was discussed at the first meeting of
the INTERGROWTH-21st Steering Committee Meeting, on
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Steering Committee Meeting on 25–27 March 2009.
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